|
Market Closed -
OTC Markets
20:12:31 04/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0650 USD | -4.41% |
|
+790.41% | -78.75% |
| 04-15 | CS Diagnostics Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-14 | CS Diagnostics Corp. Auditor Raises 'Going Concern' Doubt | CI |
Company Valuation: CS Diagnostics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Market Cap 1 | 0.3951 | 150.6 | 76.47 |
| Change | - | 38,005.96% | -49.21% |
| Enterprise Value (EV) 1 | 0.3747 | 150.6 | 76.47 |
| Change | - | 40,076.48% | -49.21% |
| P/E | -2,525x | 232,000x | 1,077x |
| PBR | 0.11x | 0.32x | 0.15x |
| PEG | - | -2,263x | 0x |
| Capitalization / Revenue | 3.13x | 1,357x | 375x |
| EV / Revenue | 2.97x | 1,357x | 375x |
| EV / EBITDA | - | - | - |
| EV / EBIT | -17x | 197,840x | 1,074x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.000198 | 0.000005 | 0.000284 |
| Distribution rate | - | - | - |
| Net sales 1 | 0.126 | 0.1109 | 0.204 |
| EBITDA | - | - | - |
| EBIT 1 | -0.022 | 0.000761 | 0.0712 |
| Net income 1 | -0.022 | 0.000761 | 0.0712 |
| Net Debt 1 | -0.0204 | -0.000501 | -0.006813 |
| Reference price 2 | 0.500000 | 1.160000 | 0.305900 |
| Nbr of stocks (in thousands) | 790 | 129,790 | 249,992 |
| Announcement Date | 29/07/25 | 29/07/25 | 15/04/26 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 1.82M | ||
| 34.6x | 4.09x | 15.38x | 2.48% | 181B | ||
| 24.27x | 4.74x | 16.63x | 1.15% | 120B | ||
| 20.89x | 3.59x | 12.86x | 2.92% | 119B | ||
| 31.27x | 3.02x | 12.17x | 2.28% | 91.44B | ||
| 18.13x | 0.21x | 13.12x | 0.72% | 63.07B | ||
| 31.81x | 7.93x | 20.4x | 1.24% | 55.8B | ||
| 39.34x | 3.62x | 12.34x | 2.11% | 54.03B | ||
| 39.01x | 9.68x | 27.09x | -.--% | 45.38B | ||
| 44.15x | 3.33x | 12.39x | 0.52% | 34.37B | ||
| Average | 31.49x | 4.47x | 15.82x | 1.49% | 76.35B | |
| Weighted average by Cap. | 29.91x | 4.21x | 15.32x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSDX Stock
- Valuation CS Diagnostics Corp.
Select your edition
All financial news and data tailored to specific country editions
















